Eltrombopag 25 MG Oral Tablet
SOOCHOW-HY-2022-08
Phase 3 small_molecule completed
Quick answer
Eltrombopag 25 MG Oral Tablet for Stem Cell Transplant Complications is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Stem Cell Transplant Complications
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed